Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


5th Ocular Diseases Drug Discovery

21 Mar 2013 - 22 Mar 2013 - San Francisco, USA



Bookmark and Share


The Ocular Diseases & Drug Development Conference taking place on March 21-22, 2013 in San Francisco, CA is now in its fifth year. As chairperson and moderator, I look forward to attending this conference. It continues to offer presentations on novel and innovative therapeutics in ocular drug development and discovery. This year we are fortunate to have Dr. Samir Patel, CEO and President of Ophthotech, as our keynote speaker. A leader in the field, Dr. Patel, a trained retina specialist, will present data from his recent clinical studies on a new and adjunct treatment for wet AMD, Fovista. We have two panels at this year's conference: 1) a safety regulatory panel with experts in the field being moderated by Dr. Ken Mandell and 2) a VC/ BD panel being moderated by Dr. Emmett Cunningham. This forum allows for excellent networking, the exchange of ideas, and sharing of challenges; all with a united common goal of bringing new and innovative treatments to patients in the area of ophthalmology.

The conference features the following topics:

Session: Novel Targets, Developments and Technologies

Session: Novel Drug Delivery Methods to the Anterior and Posterior Segments

Session: Clinical Development Advances & Updates 

Session: Safety Assessment and Regulatory Landscape in Ocular Drug Development

Session: Short Presentations

Panel Discussion: BD, Investments and Potential for Collaborations

Panel Discussion: Safety and Regulatory in Ocular Development



Further information
Scientific News
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Simplifying Gene Testing Access for Ovarian Cancer Patients
Simplifying access to gene testing for women with ovarian cancer improves treatment choices and could save lives.
New Protein Model Could Accelerate Drug Development
Stony Brook-led international research team creates ultra-fast approach to model protein interactions.
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
New Skin Cancer Drugs with Surprising Powers
Inserm team synthesizes and developed new drugs for melanoma.
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!